A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
2020 · New England Journal of Medicine · 5,464 citations
https://doi.org/10.1056/nejmoa2001282
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
0
Citations
0
h-index
0
i10-index
Peng Lu is an academic researcher from Zhejiang University. The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Pituitary Gland Disorders and Treatments & Adrenal and Paraganglionic Tumors.
ORCID: 0000-0002-9200-7896https://doi.org/10.1056/nejmoa2001282
https://doi.org/10.1007/s00204-013-1078-5
Click to start Chat